COVID-19 Updates, Vaccines, and Live Q&A

May 27, 2021

Watch the video below to get the latest updates on COVID-19 and recommendations for people affected by Crohn's or colitis. Expert gastroenterologists answer commonly asked questions about COVID-19 vaccines and the impact of IBD medications.

Moderators

Dr. Gilaad Kaplan (MD, MPH, FRCPC), Professor of Medicine, Gastroenterologist and Epidemiologist, Departments of Medicine and Community Health Sciences, University of Calgary, Past Chair of the Scientific and Medical Advisory Council, Crohn's and Colitis Canada l Twitter: @gilkaplan

Dr. Eric Benchimol (MD, PhD, FRCPC), Professor, Pediatric Gastroenterologist, Department of Paediatrics, The Hospital for Sick Children (SickKids) and University of Toronto, Division of Gastroenterology, Hepatology and Nutrition, SickKids, NASPGHAN Canadian Councilor, Chair of the Scientific and Medical Advisory Council, Crohn's and Colitis Canada | Twitter: @ericbenchimol For more information on COVID-19 and IBD, please visit www.crohnsandcolitis.ca/covid-19

Want to help boost our research initiatives?

Text CURE to 20222 to donate $25 to Crohn’s and Colitis Canada’s critical research projects.

READ MORE

Quick FactFaits en bref

Canada has among the highest incidence rates of Crohn's and colitis in the world.
1 in 140 Canadians lives with Crohn’s or colitis.
Families new to Canada are developing these diseases for the first time.
Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
People are most commonly diagnosed before age 30.

Webinars and updates

COVID-19 Updates, Vaccines, and Live Q&A

Quick FactFaits en bref

Other Areas of Interest